Organization
H. Lundbeck A/S
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
H. Lundbeck A/S
... of R&D, and to maximize the commercial potential of the marketed products. Lundbeck is the company that has embraced this strategy more than others. It ...
... and better treatments for schizophrenia. Forming a partnership with Vanderbilt University (Vanderbilt), Lundbeck both acquires an exclusive license and enters a research collaboration regarding Vanderbilt's ...
... price of $5 million upfront in 2014—has now gone the way of Lundbeck’s idalopirdine, a 5-HT6 inhibitor that failed in late-stage Alzheimer’s testing in 2016. ...
... show chapters Lundbeck Lundbeck and 23andMe team up for depression study 4:30 PM ET Mon, ...
... just been approved by the China Food and Drug Administration. Already today Lundbeck is the market leader in the anti-depressant market in China as approximately ...
... Speciale, CPA 314-654-3638 Director, Investor Relations * Sabril®, a registered trademark of Lundbeck, is FDA-approved for the treatment of infantile spasms in infants one month ...
... Lundbeck today presented data at the American Epilepsy Society (AES) Annual Meeting in ...
... Teva was expected when Kåre Schultz, who pushed for a rejig at Lundbeck, came on board as CEO. Schultz did live up to his reputation ...
... Eisai/Pfizer) · Exelon (rivastigmine; Novartis) · Razadyne (galantamine; Janssen/Shire) · Namenda/Ebixa (memantine; Merz/Allergan/Lundbeck) Phase III therapies · Verubecestat (MK 8931; Merck & Co.) · Elenbecestat ...
... for the 9 leading treatments for Parkinson's Disease from AbbVie, Britannia, GSK, Lundbeck, Meda Pharma, Novartis, Teva, UCB and Zambon. It shows: · How physicians ...
... first agent approved for the treatment of agitation in AD, followed by Lundbeck/Otsuka's brexpiprazole, which will begin a third Phase III trial in 2018. We ...
... load. Schultz reduced headcount by 25 percent at his former pharmaceutical firm Lundbeck A/S in Denmark. This was followed by markedly improved profitability at Lundbeck, ...
... Teva—to a permanent post. RELATED: Teva finally nabs a CEO, and it's Lundbeck helmsman—and Novo ex—Kåre Schultz But the changes at Teva won’t end there. ...
... Business Authority. mavk@lundbeck.com Mads Kronborg Tel: +45 36 43 40 00 About Lundbeck H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is a global pharmaceutical company ...
... SA, AFFiRiS AG, BioArctic AB, Biogen Inc, Evotec AG, Genmab A/S, H. Lundbeck A/S, ICB International Inc, MedImmune LLC, Neuropore Therapies Inc, nLife Therapeutics SL, ...
... show chapters Lundbeck Lundbeck and 23andMe team up for depression study 4:30 PM ET Mon, ...
... Valby, Denmark - H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons ...
... get involved: Back by popular demand! Join our round table sessions with Lundbeck, CSL Behring, OPKO biologics and Cheisi on key topics facing the industry ...
... How quickly fortunes change. Last quarter, Lundbeck's then CEO Kåre Schultz got to report that the Danish drugmaker had ...
... Takeda Pharmaceuticals U.S.A., Inc. (Takeda), Lundbeck U.S. and Advocate Health Care today announced a collaboration focusing on the ...
... clinical trials for the agitation indication that were completed by Otsuka and Lundbeck earlier this year. Top-line results for the completed trials were announced May ...
... clinical trials for the agitation indication that were completed by Otsuka and Lundbeck earlier this year. Top-line results for the two completed trials were announced ...
... clinical trials for the agitation indication that were completed by Otsuka and Lundbeck earlier this year. Top-line results for the two completed trials were announced ...
Want to see the full history on H. Lundbeck A/S? Upgrade to RelSci Pro now!
Start My Free Trial